Global Coalition on Aging Hosts Cross-Sector Roundtable to Tackle Heart Valve Disease in Aging Societies

Silent epidemic of heart valve disease is critical barrier to healthy aging in the 21st century.

New York, NEW YORK (March 23, 2023) – The Global Coalition on Aging (GCOA) and the Global Heart Hub have released a global position paper “Heart Valve Disease: Harnessing Innovation to Save Lives, Mitigate Costs, and Advance the Healthy Aging Agenda.” The report builds upon on a December 2022 GCOA-GHH roundtable of cross-sector experts and examines how behavior and policy change can best address heart valve disease in our 21st century.

“The impacts of heart valve disease are all the more tragic because they are largely avoidable,” said Michael Hodin, CEO of the Global Coalition on Aging. “The prevalence and incidence is growing apace with the aging of our society. It’s past time for societies and health systems to unleash the medical innovations that are now available and those still to come in future. In doing so, we will help achieve a healthier aging and align to economic benefits for all.”

As population aging accelerates, heart valve disease is growing as both a life-threatening health challenge and a costly drain on health systems and public budgets. In the United States alone, prevalence has grown from just 5 million in 2000 to as many as 11.6 million in 2018, costing $23.5 billion in direct health expenditures each year; in Europe, one in eight people over 75 suffers from moderate to severe heart valve disease, and the number of patients with heart valve disease is expected to double by 2040. Yet the disease remains widely under-recognized due, at least in part, to ageist biases. For example, early symptoms like shortness of breath or tiredness risk being dismissed as all too common among older adults, when they can really be signs of heart valve disease. Despite increasing innovation for intervention, care models, and technologies, heart valve disease in this sense is a near perfect illustration of how ageism adversely shapes our health care. This creates a clear opportunity to better utilize the tools already available to improve diagnosis and treatment, streamline care pathways, and, ultimately, save lives.

“In the clinic, I see that people with heart valve disease are getting sicker, younger,” said Ariane Macedo, MD, MHS, PhD, Clinical Cardiologist, Santa Casa de São Paulo; Director, Galen Academy; and Member, Scientific Committee, Instituto Lado a Lado pela Vida. “We must implement solutions to engage people faster, detect and diagnose the disease earlier, and make patients aware of all available treatments.”

In light of this opportunity, and aligned with the UN Decade of Healthy Ageing, the experts at the roundtable called on policymakers; health system leaders; patients, caregivers, and their advocates; healthcare providers; and other stakeholders to prioritize and strengthen responses to heart valve disease. Together, a multi-sector coalition of leaders and organizations can combat ageist stereotypes that constrain care, improve early detection and diagnosis, and ensure increased and widespread access to life-saving interventions.

The roundtable of multi-disciplinary experts found that greater urgency is needed to ensure that patients and families, health systems, and societies reap the full benefits of recent life-saving innovations. This will happen only if:

  • There is greater awareness globally and across stakeholder disciplines;
  • Health systems respond with equitable access, reimbursement, and encouragement for the use of innovations; and
  • Heart valve disease is recognized globally as a central element of the Decade of Healthy Aging.

“We need to transform the relationship between people with heart valve disease and their care teams,” said Susan Strong, Founding President, Director of Patient Engagement, Heart Valve Voice US and Heart Valve Disease Patient. “This should be a true partnership, empowering people to understand the disease, their treatment options, and long-term care plans.”


About the Global Coalition on Aging

The Global Coalition on Aging aims to reshape how global leaders approach and prepare for the 21st century’s profound shift in population aging. GCOA uniquely brings together global corporations across industry sectors with common strategic interests in aging populations, a comprehensive and systemic understanding of aging, and an optimistic view of its impact. Through research, public policy analysis, advocacy, and strategic communications, GCOA is advancing innovative solutions and working to ensure global aging is a path for fiscally sustainable economic growth, social value creation and wealth enhancement.


About the Global Heart Hub

The Global Heart Hub is the first global non-profit organisation established to provide a voice for those affected by cardiovascular disease. We are an alliance of heart patient organisations, aiming to create a unified global voice for those living with or affected by heart disease.

Our aim is to unite patient groups from every country in the world under the umbrella of the Global Heart Hub. Our combined mission is to raise awareness of heart disease and the challenges it presents in everyday life. The Global Heart Hub is a platform for heart patient organisations to share their views, learn from each other’s best practice, unite on common advocacy goals, and share resources. We aim to increase awareness and understanding of the many heart conditions that exist, improve patient outcomes, enhance quality of life, and optimise longevity and healthy aging.

For more information, visit:

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Brazil Must Fight Antibiotic Resistance

The threat posed by antimicrobial resistance is urgent and spares no country - including Brazil. According to The Lancet, 63 deaths per 100,000 are associated with AMR in Brazil and Paraguay, a rate that exceeds the average for Latin America and the Caribbean. AMR-associated deaths in Brazil are second only to cardiovascular diseases and cancers.

We Missed 100 Million Adult Vaccines – Here’s How We Get Back on Track

Like other pandemics throughout human history, COVID-19 has caused profound changes that are still rippling through our societies, even as people are understandably eager to move on. In fact, these impacts are all the more dangerous when they are largely ignored or effectively invisible. The decline in adult vaccination may be one of the most significant, as a new report finds that ~100 million doses were missed in 2021 and 2022 alone – reversing global progress towards widespread adult immunisation as a new standard of care in a world of more old than young.

New Analysis Shows Lost Ground on Adult Immunisation During the Pandemic with 100 Million Doses Potentially Missed

New data shared today by GSK, in collaboration with the IQVIA Institute for Human Data Science and the Global Coalition on Aging (GCOA), estimate approximately 100 million fewer doses of some adult vaccines (excluding Covid-19 vaccines) were administered in 2021 and 2022 than anticipated, based on the global vaccination adoption trends observed from 2013 to 2020, compounding already low adoption rates pre-pandemic.

Going Beyond Applause: The Potential of Caregiving to Unlock Job Opportunities of the Future

Early in the COVID-19 pandemic, the role of caregivers – staff and family who provide care for older and dependent people to carry out activities such as eating or moving - catapulted to the front of our collective conscience. The daily applause for front-line care workers showed a high level of recognition for their incredible work and provided insight into how our health systems must change as our society ages. We need to continue to recognise caregivers as essential to our ageing society.

High-Level Forum on the Silver Economy 2023

Join us for the High-Level Forum on the Silver Economy 2023. Now in its fourth year, the Silver Economy Forum 2023, December 6 and 7, will explore aging at every stage of life, looking at the growing global Silver Economy through a multigenerational lens. Linking to the goals and aspirations of the UN Decade of Healthy Ageing, SEF 2023 will highlight key themes at the intersection of aging at every age, and the Silver Economy.

Global Coalition on Aging Workshop Calls on G7 Countries to Fund Pull Incentives to Spur Antibiotic Innovation

The Global Coalition on Aging, in partnership with JPMA, today announced the release of its workshop report on the AMR crisis facing G7 countries and the world, “The Value of Pull Incentives in Japan to Encourage Investment in Antibiotic Innovation to Solve the AMR Crisis.” If strong action is not taken to address AMR, we will lose the antibiotics we need to cure infections, which is likely to outpace cancer as a major cause of death, killing an estimated 10 million by 2050.